Recall for EpiPens after defect found

Four batches of life-saving EpiPens are being recalled after they were found to possibly contain a defect that could prevent them from injecting properly.

EpiPens are used in emergency situations to treat people who are having severe allergic reactions.

If they don't activate properly, there is a risk a patient may not receive the required dose of adrenaline in a timely manner or they may not get the dose at all.

The Therapeutic Goods Administration is urging people with the EpiPen 300 microgram adrenaline injection syringe auto-injectors to check the batch number and expiry date on either its label of the end of the carton.

Those from batches 5FA665, 5FA6651, 5FA6652 and 5FA6653, all expiring in April 2017, should return them to any pharmacy to swap for one from a different batch for free.

The TGA has confirmed two reports of auto-injectors from these batches failing to activate correctly, out of about 80,000 devices distributed worldwide.

No other batches of EpiPen, including the EpiPen Jr 150 microgram version, are thought to be affected, the TGA said.

© AAP 2017

You May Also Like...

  • Police seeking missing Howrah woman
    Tasmania Police is seeking public assistance in its search for Howrah woman Esther Miranda Cashion. Ms Cashion was last seen on March 10th and is...
  • US girl allegedly raped on Facebook Live
    A 15-year-old Chicago girl was allegedly gang-raped while the attack was streamed live on Facebook. None of the roughly 40 people who watched the...
  • Reclaim the Lane - Devonport
    For it's sixth consecutive year, RECLAIM the LANE returns to Rooke Lane for the National Youth Week on Friday April 7th 3.30 - 5.30pm. This free...
  • Vic teen calls for rape court reform
    Victoria's premier and attorney-general will meet with a teenage rape victim to discuss how to make the court system less traumatic. The family...